Drosophila as a model to study mitochondrial dysfunction in Parkinson's disease.
about
MUL1 acts in parallel to the PINK1/parkin pathway in regulating mitofusin and compensates for loss of PINK1/parkinReceptor-mediated mitophagy in yeast and mammalian systemsDopamine dynamics and signaling in Drosophila: an overview of genes, drugs and behavioral paradigmsEvaluation of traditional medicines for neurodegenerative diseases using Drosophila modelsParkinson's disease: animal models and dopaminergic cell vulnerabilityDrosophila sodium channel mutations: Contributions to seizure-susceptibilityBcl-2 homologue Debcl enhances α-synuclein-induced phenotypes in Drosophila.The Bcl-2 homologue Buffy rescues α-synuclein-induced Parkinson disease-like phenotypes in Drosophila.Loss of a Clueless-dGRASP complex results in ER stress and blocks Integrin exit from the perinuclear endoplasmic reticulum in Drosophila larval muscle.PINK1/Parkin-Dependent Mitochondrial Surveillance: From Pleiotropy to Parkinson's Disease.Behavioral Phenotyping and Pathological Indicators of Parkinson's Disease in C. elegans Models.Mitochondrial contagion induced by Parkin deficiency in Drosophila hearts and its containment by suppressing mitofusin.Early Expression of Parkinson's Disease-Related Mitochondrial Abnormalities in PINK1 Knockout Rats.Regulation of mitochondrial morphology and function by stearoylation of TFR1.Optimization of wrMTrck to monitor Drosophila larval locomotor activity.Selective removal of deletion-bearing mitochondrial DNA in heteroplasmic Drosophila.Equine metabolic syndrome impairs adipose stem cells osteogenic differentiation by predominance of autophagy over selective mitophagy.PINK1-dependent phosphorylation of PINK1 and Parkin is essential for mitochondrial quality control.Valosin-containing protein (VCP/p97) inhibitors relieve Mitofusin-dependent mitochondrial defects due to VCP disease mutants.Network modeling to identify new mechanisms and therapeutic targets for Parkinson's disease.Fruitful research: drug target discovery for neurodegenerative diseases in Drosophila.New insights on the mitochondrial proteome plasticity in Parkinson's disease.How mitochondrial dynamism orchestrates mitophagy.Parkin-dependent mitophagy in the heart.Central Parkin: The evolving role of Parkin in the heart.TOMM40 and APOE Gene Expression and Cognitive Decline in Japanese Alzheimer's Disease Subjects.SLP-2 interacts with Parkin in mitochondria and prevents mitochondrial dysfunction in Parkin-deficient human iPSC-derived neurons and Drosophila.Evaluation of antiparkinson activity of PTUPB by measuring dopamine and its metabolites in Drosophila melanogaster: LC-MS/MS method development.Understanding Miro GTPases: Implications in the Treatment of Neurodegenerative Disorders.Drosophila as a Model System for Neurotransmitter Measurements.Overexpression of Buffy enhances the loss of parkin and suppresses the loss of Pink1 phenotypes in Drosophila.The HtrA2 Drosophila model of Parkinson's disease is suppressed by the pro-survival Bcl-2 Buffy.Mitochondrial Quality Control in Neurodegenerative Diseases: Focus on Parkinson's Disease and Huntington's Disease.Live Imaging Mitochondrial Transport in Neurons.
P2860
Q24298771-84D35F7B-C8DD-4CEA-B1B1-CA99974277B6Q26821921-195F7B81-8351-4997-B886-A90DE4932226Q26852387-6CE0DB37-9542-49CB-B147-A4DD21EE0DB9Q27027455-F7A7B850-9DD7-47C8-8C4D-40B9794AC192Q28080503-BC78F81E-9132-4ED6-AF41-001BCB0D53DDQ28082964-D2C4C5DF-7AC4-4AB2-8EF1-25C46661E600Q30356412-500CA588-3F53-4516-A582-E9CBA2BDEC78Q30359012-E263AEDF-6D66-4FC5-AA4C-C8910CDC6D33Q30650873-C5B65EB2-8CE6-492A-8643-6969478E6889Q33619324-3E53DDAA-0EC7-40EE-BF91-5D1456BC8806Q33790301-3E9A7516-CB01-43A9-A65D-1BFEA28C4C95Q35359238-32F07240-2410-447F-BCB7-6028B013BCF3Q35642539-4C62E45A-5665-4EF6-B8C5-B97BA0B0E3F6Q36032578-EB56E83F-4429-4892-885B-D96A9A455802Q36080563-113069F8-0695-454C-B696-595A9483C0DDQ37421594-DC613E59-3888-4E37-A4AB-A09B176F05F3Q37466859-42F2E9E7-A6B9-49AF-9EC7-BEEA0FBB6165Q37603514-D2F993E0-658C-4435-A518-3F0B2CEAF05BQ37714188-8FD04CEE-1DE1-486E-A6AE-D492718CDEADQ38112215-0E6C109B-1364-4514-9B40-4BF13025BFFBQ38154940-BD6EC58A-86DE-4038-BD63-CF9DE708D4C7Q38452561-6E2DA323-53FF-4976-B417-5B8FF53457A8Q38497008-81A0088E-C27D-472C-AA29-F609B359342CQ38649668-0880597B-01A5-497F-88AD-3F5A5558C2E2Q38780774-7CFC3EC2-492B-46C0-9E92-E502263B0C1CQ47604652-6F7991FE-0DB4-47DF-98D0-3829083C0E1DQ47928029-9954D3F5-509C-45FD-BA72-148B5E7CAE5FQ47953729-09FEF00F-91DA-444E-A282-5635EDA2435DQ48092663-5F883343-D24F-4054-9065-244A5EDB8076Q50056855-063ED382-8754-4709-8E8F-6E08242FA617Q50259029-A7715C2B-FC08-4069-AF01-10FB1126F312Q51325327-3C27078D-22C3-4D18-A289-B53C7269A960Q55081064-B5A26F08-AB7A-49A5-8449-E8465F40B735Q55409966-1B96CC3D-E2A5-46DB-8203-B11A08A4FC59
P2860
Drosophila as a model to study mitochondrial dysfunction in Parkinson's disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Drosophila as a model to study mitochondrial dysfunction in Parkinson's disease.
@ast
Drosophila as a model to study mitochondrial dysfunction in Parkinson's disease.
@en
type
label
Drosophila as a model to study mitochondrial dysfunction in Parkinson's disease.
@ast
Drosophila as a model to study mitochondrial dysfunction in Parkinson's disease.
@en
prefLabel
Drosophila as a model to study mitochondrial dysfunction in Parkinson's disease.
@ast
Drosophila as a model to study mitochondrial dysfunction in Parkinson's disease.
@en
P2860
P1476
Drosophila as a model to study mitochondrial dysfunction in Parkinson's disease.
@en
P2093
P2860
P356
10.1101/CSHPERSPECT.A009944
P577
2012-11-01T00:00:00Z